| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.06. | Ardent Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.06. | Ardent Health's surprise CEO change reflected need for margin focus amid headwinds, CFO says | 2 | FierceHealthcare | ||
| 07.06. | Chutes & Ladders-Ardent Health appoints new CEO; KFF Founding President, CEO to retire | 5 | FierceHealthcare | ||
| 03.06. | Ardent Health Names Dave Caspers President, CEO; Backs FY View After Q2 Volume Softness; Stock Down | 13 | RTTNews | ||
| 02.06. | Ardent Health names insider Dave Caspers CEO | 1 | Seeking Alpha | ||
| ARDENT HEALTH Aktie jetzt für 0€ handeln | |||||
| 02.06. | Führungswechsel bei Ardent Health: Dave Caspers wird neuer CEO | 1 | Investing.com Deutsch | ||
| 02.06. | Ardent Health names Dave Caspers as new CEO | 1 | Investing.com | ||
| 26.05. | Ardent Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.05. | Ardent Health steigert EBITDA um 26 %, Aktie gibt nach verfehlten Gewinnerwartungen nach | 3 | Investing.com Deutsch | ||
| 12.05. | Ardent Health Q1 2026 slides show 26% EBITDA growth amid challenges | 1 | Investing.com | ||
| 12.05. | Ardent Health steigert Umsatz, verfehlt aber Gewinnziel - Aktie gibt nach | 1 | Investing.com Deutsch | ||
| 06.05. | Ardent Health, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 06.05. | Ardent Health steigert Umsatz im ersten Quartal 2026 um 7 %, Aktie gibt dennoch nach | 5 | Investing.com Deutsch | ||
| 06.05. | Transcript: Ardent Health Partners Q1 2026 Earnings Conference Call | 1 | Benzinga.com | ||
| 06.05. | Starke Q1-Zahlen: BofA hebt Kursziel für Ardent Health an | 5 | Investing.com Deutsch | ||
| 26.03. | Ardent Health 4Q25 slides: strong year ends with challenging quarter | 2 | Investing.com | ||
| 16.03. | Ardent Health, Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
| 09.03. | RBC Capital lowers Ardent Health stock price target on revised estimates | 1 | Investing.com | ||
| 09.03. | KeyBanc bestätigt "Sector Weight"-Rating für Ardent Health | 5 | Investing.com Deutsch | ||
| 09.03. | KeyBanc reiterates Sector Weight on Ardent Health stock | 5 | Investing.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS | 2,080 | -0,95 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds | $4.5 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon exercise in full of warrants
SEATTLE, June 12, 2026 /PRNewswire/... ► Artikel lesen | |
| BUTTERFLY NETWORK | 5,765 | -0,29 % | Michael Burry sagt nur: wow: Butterfly +56 %: Die kleine Aktie hinter Midjourneys 60-Sekunden-Körperscanner | © Foto: Jaque Silva - NurPhotoMidjourney plant einen 60-Sekunden-Körperscanner per Ultraschall und KI. Butterfly liefert die Technik für den Prototyp. Anleger haben die Aktie am Donnerstag brutal hochgekauft... ► Artikel lesen | |
| BEYOND AIR | 5,705 | +2,24 % | XFRA NEW INSTRUMENTS AVAILABLE ON 13.07.2026 | The following instruments on XETRA do have their first trading 13.07.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 13.07.2026
Aktien
1 CY0201461213 Pelican Aqua Holding... ► Artikel lesen | |
| AXOGEN | 34,820 | -0,06 % | Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026 | ||
| AETHLON MEDICAL | 0,670 | +3,48 % | Aethlon Medical, Inc.: Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier | Second cohort findings consistent with previously reported observations; independent statistical analysis planned following completion of all three patient cohorts
... ► Artikel lesen | |
| AVANOS MEDICAL | 21,200 | -0,93 % | Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger | ALPHARETTA, Ga. and NEW YORK, July 2, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) ("Avanos") and American Industrial Partners ("AIP") jointly announced... ► Artikel lesen | |
| ANGIODYNAMICS | 12,100 | -0,82 % | H.C. Wainwright raises AngioDynamics stock price target on growth | ||
| APYX MEDICAL | 3,700 | -2,63 % | Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System | CLEARWATER Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics products marketed and sold as Renuvion... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 8,440 | -0,12 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Application for quotation of securities - AVR | ||
| ADAPTHEALTH | 10,955 | -0,05 % | AdaptHealth Flags Material Breach After Threat Actor Accessed Patient Management Systems | ||
| BLUEJAY DIAGNOSTICS | 1,465 | +1,03 % | Morning Market Movers: Bluejay Diagnostics, Decent Holding, Abits Group, Sunshine Biopharma See Big Swings | WASHINGTON (dpa-AFX) - At 7:35 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| AUTONOMIX MEDICAL | 4,560 | +2,47 % | Autonomix Medical, Inc.: Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform | Newly Issued Patent Expands Company's Neural Sensing Technology Platform into Large Urology Market Affecting Approximately 37 Million Americans THE WOODLANDS, TX, July 15, 2026 (GLOBE NEWSWIRE) --... ► Artikel lesen | |
| AGAPE ATP | 3,095 | +0,81 % | Agape ATP (ATPC) Stock Rallies Over 42% After Hours: Here's What Is Going On | ||
| BONE BIOLOGICS | 1,150 | -1,71 % | Bone Biologics Corp - 8-K, Current Report | ||
| ADVANCED BIOMED | 5,030 | -1,37 % | Advanced Biomed Inc. - 8-K, Current Report |